kinamycin A

Known as: 2,3,4-tri(acetyloxy)-1,2,3,4,6,11-hexahydro-1,7-dihydroxy-3-methyl-6,11-dioxo-5H-benzo(b)carbazole-5-nitrile 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2017
0120062017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND/AIM Kinamycin F is a bacterial metabolite which contains an unusual and potentially reactive diazo group that is known… (More)
Is this relevant?
2015
2015
Here we report that both PLCβ1a and PLCβ1b are relevant regulators of erythropoiesis in that kinamycin F, a potent inducer of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
The bacterial metabolite kinamycin F, which contains an unusual and potentially reactive diazo group, is being investigated as an… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
An efficient three-step construction of the highly oxygenated D-ring of the kinamycin antibiotics is reported for a simple model… (More)
  • figure 1
  • figure 2
Is this relevant?
2007
2007
The bacterial metabolite kinamycin F, which is being investigated as a potent antitumor agent, contains an unusual and… (More)
Is this relevant?
2006
2006
The cell growth and cell cycle inhibitory properties of the bacterial metabolites kinamycin A and kinamycin C were investigated… (More)
Is this relevant?